Trial
NCT01370863
An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Shire
Collaborators
—
Condition
Gastroesophageal Reflux Disease
Intervention
SPD557
Why stopped
This study was terminated early due to recruitment difficulties. There were no safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-10